Generic pharma plaintiffs say states’ Teva case should be among first tried

Spencer Parts

10 July 2020

Shutterstock/Fahroni

Drug purchasers suing generic pharmaceutical companies for an alleged antitrust conspiracy have told a federal judge that the case brought by a large group of state attorneys general centred on Teva Pharmaceuticals should be among the first to go to trial.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.

Subscribe now

Already have access? Login below

Spencer Parts

View full biography

Author

Tipline

Burning the midnight oil: The Tipline for 15 April 2021
The House Judiciary Committee ran a legislative markup marathon yesterday, debating amendments to various legislative proposals from 10am until the wee hours of this morning. The digital platforms report published by House antitrust subcommittee staff in October served as the final act. Several Republican members unsuccessfully pushed for changes condemning “anti-conservative bias” on the part of large technology companies while multiple Democrats sang praises for subcommittee chair David Cicilline and his work on the …
Who’s on first?: The Tipline for 14 April 2021
Not the FTC’s COPA tea: The Tipline for 13 April 2021

Generic pharma plaintiffs say states’ Teva case should be among first tried

Subscribe to Global Competition Review

Subscribe and start reading now

Already have access? Login below

Related Topics

Spencer Parts